Maria Rudnytska

I am a research assistant working in the Watkins Group to develop a cure for inherited cardiomyopathies within the CureHeart Project. My role involves studying the genetic variants that cause inherited cardiomyopathies and developing genetic therapies that can target the underlying cause of the disease.

Prior to my position in Oxford, I completed my MSci degree in Molecular Genetics at King’s College London. During this time, I conducted a project focused on using two gene-editing technologies called base and prime editing to edit pathogenic mutations that cause a severe skin disorder called recessive dystrophic epidermolysis bullosa (RDEB).

Currently, I am using gene-editing technologies and patient-derived human induced pluripotent stem cells (hiPSCs) from patients with inherited cardiomyopathies to develop and optimise genetic therapies.